Kaiser Permanente is deeply concerned about the burden high drug prices impose on our members and on our ability to carry out our mission.
Patients, taxpayers, health care systems, and drug companies all deserve fair and reasonable solutions. It is time for a new framework for drug pricing that more effectively rewards innovation and discoveries, and also provides medicines at prices patients can afford.
We’ve advocated for policies that:
The market for prescription drugs is complex and dysfunctional. We encourage policymakers to look for the root problems to help us build a prescription drug market that will be sustainable for years to come.
1 Cost to U.S. health system from 2019 drug price hikes with no evidence of increased clinical value, 2021.
2 AARP, 2021.
3 Rand Corporation, 2021.
With the right policies and partnerships, artificial intelligence can lead …
A class of drugs that makes care more affordable has emerged over the last …
Kaiser Permanente supports the ballot measure to expand and improve mental …
CityHealth’s 2023 Annual Policy Assessment awards cities for their policies …
Better public policies can help address the challenges. We encourage policymak …
Researchers and organizations are exploring inventive ways to reduce gun …
The health care industry is responsible for 8% to 10% of harmful emissions …
Kaiser Permanente is working to address drug shortages and support policies …